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Abstract 
The present study characterizes for the first time a GSH specific transporter in a human intestinal epithelial cell line 
(I407). GSH metabolism is very important for the antioxidant and detoxifying action of intestine and for the maintenance of
the luminal thiol-disulfide ratio involved in regulation mechanisms of the protein activity of epithelial cells. GSH level 
decreases have been related to physio-pathological alterations either of intestine or other organs. GSH specific transport 
systems have been identified in membranes of various cell types of rat, mice and rabbit. The presence of a Na+-independent 
transport system of GSH is confirmed by the similar behaviour of GSH uptake time-courses when Na + in extracellular 
uptake medium was replaced with choline + or K + as well as by kinetic saturation and by the trans-stimulation effect on 
GSH uptake in GSH preloaded cells. Moreover, this transporter is activated when cations are present in extracellular 
medium and it is affected by membrane potential changes with an increase in GSH uptake values when membrane 
depolarization occurs. The present results also show a remarkable affinity and specificity of this transporter for GSH; in 
fact, K m value is very low (90 _+ 20/xM) and only compounds strictly related to GSH structure, such as GSH S-conjugates 
and GSH-ethyl ester, inhibit GSH uptake in I407 cells. Finally, a possible hormonal control and modulation by the 
thiol-disulfide status of GSH transporter activity is suggested. © 1997 Elsevier Science B.V. 
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1. Introduction 
GSH and GSH-related enzymes are present in 
different segments of human intestine and gastric 
mucosa [1]. GSH is involved in detoxification pro- 
Abbreviations: 7-GT, y-glutamyltranspeptidase; BME, Eagle' s
Basal Medium; PBS, phosphate-buffered saline; BSO, L- 
buthionine sulfoximine; ATiz 5, Acivicin ((L-c~S,5S)-a-amino-3- 
chloro-4,5-dihydro-5-isoxozoleacetic id); y-GCS, y-glutamyl- 
cysteine synthetase; GST, GSH-S-transferases; GR, GSSG-re- 
ductase; GPx, GSH-peroxidase; BBMV, brush-border membrane 
vesicles 
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cesses, in regulating the intracellular redox state and 
the activity of proteins as enzymes, transporters, re- 
ceptors [2-6]. Alteration of GSH levels in certain 
physiological and pathological conditions have been 
demonstrated in several tissues. The intestine is the 
first organ that may be attacked by ingested toxic 
chemicals and carcinogens [7], and changes in intesti- 
nal GSH content have been related to an increased 
susceptibility to carcinogenesis [8], oxidative injury 
[3,9], and metal intoxication [10] as well as to typical 
intestinal pathologies [11]. Oral therapeutic adminis- 
tration of GSH has been suggested, and increases of 
GSH in rat intestinal mucosa after oral GSH adminis- 
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tration have been measured in different studies 
[3,11-13]. Moreover, it has been demonstrated that 
dietary GSH can be absorbed intact in rat and that the 
upper jejunum is the principal site of GSH absorption 
[14,15]. 
Different mechanisms of GSH uptake through in- 
testinal membranes have been suggested [3]; how- 
ever, the main experimental evidences demonstrate 
that GSH uptake in different animal species occurs 
by two mechanisms: 
(1) By the cleavage of GSH into its constituent 
amino acids (Glu, Cys, Gly) through y-gluta- 
myltranspeptidase (y-GT) and a dipeptidase activity, 
followed by their subsequent absorption and intra- 
cellular GSH resynthesis. 
(2) By specific transporters. 
Both processes are independent and may occur 
simultaneously [16]; however, the second mechanism 
is less complex, faster and involves less consumption 
of energy. In various cell types specific GSH trans- 
port systems have been identified [12], and recently 
Yi et al. [17] have demonstrated that cDNA of the rat 
canalicular GSH transporter hybridizes with a single 
transcript isolated from rat brain, kidney, lung and 
small intestine. In particular a Na+-independent facil- 
itated transport for GSH and GSH S-conjugates in 
vesicles obtained from purified brush-border rabbit 
membranes [18] and a GSH Na+-dependent trans- 
porter in vesicles obtained from rat basolateral mem- 
branes [19] have been characterized. The presence of 
these specific transporters atboth intestinal cell poles 
may be important for the absorption of dietary and 
bile-derived GSH; for the maintenance of high GSH 
levels in intestine and in plasma; and finally for 
supplying other organs with GSH [12,13]. Moreover, 
these transporters may eliminate GSH S-conjugates 
directly into lumen or participate in their transloca- 
tion from the liver to the kidney [ 16,20], contributing 
to the protective action of intestine against exogenous 
and endogenous noxious compounds. 
A hormonal regulation of rat intestinal GSH ab- 
sorption has also been demonstrated, and a physio- 
logical role of GSH in intestine has been suggested 
[21]. However, at present no data exist about trans- 
membrane transporters of GSH in human intestine. 
The present study was undertaken to characterize 
GSH uptake in a human intestinal cell line (1407) 
derived from embryonic small intestine [22]. We 
employed the I407 cell line to study GSH transport in 
non transformed cells and in cells of small intestine, 
in which GSH absorption seems mainly to occur. 
Moreover, I407 cells are a useful experimental model 
to study GSH-mediated transport, considering that 
these undifferentiated cells do not have y-GT, the 
only known membrane nzyme that can break down 
y-glutamyl linkage of GSH [23]. GSH transport was 
studied under different experimental conditions in 
order to determine the presence, activity and speci- 
ficity of the GSH-mediated transport system. 
2. Materials and methods 
[glycine-2-3H]GSH (spec. act. 43.8 Ci/mmol) and 
2-deoxy-D-[ 3 H]glucose (spec. act. 8.2 Ci/mmol) and 
L-[1-HC]glucose (spec. act. 55 mCi/mmol) were ob- 
tained from New England Nuclear Du Pont (Boston, 
MA). 
Nitrocellulose filters (5 /zm pore size) were from 
Sartorius (G~Sttingen, Germany). The dye-reagent 
concentrate for the determination f protein was ob- 
tained from Bio-Rad. All other chemicals used were 
reagent grade and were obtained from commercial 
sources. 
2.1. Cell culture 
Intestine 407 cells derived from undifferentiated 
crypt cells of fetal human small intestine were ob- 
tained from ATCC (Rockwille MD, USA). Cells 
were grown in Eagle's Basal Medium (BME) supple- 
mented with 15% fetal calf serum at 37°C in a 
humidified atmosphere of 95% air and 5% CO 2. For 
the experiments cells grown to confluence in 100-mm 
dishes and in 22-mm dishes were utilized. 
2.2. Radiolabeled substrate uptake 
Monolayers were washed twice in isotonic phos- 
phate-buffered saline, pH 7.4 (PBS) and collected by 
scraping with a rubber policeman. After centrifuga- 
tion (1000 × g for 10 min) the pelleted cells were 
resuspended in Krebs solution pH 7.4 and utilized to 
measure GSH, glucose uptake and protein concentra- 
tion. The uptake of radiolabeled substrates was per- 
formed by a rapid filtration method as described by 
Vincenzini et al. [18]. GSH uptake was carded out at 
37°C in 8 × 105 cells in Krebs solution pH 7.4 
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containing 1 mM dithiothreitol, 200 /zM GSH and 
0.4/xCi [3H]GSH or 200/xM 2-deoxy-D-glucose and 
0.8 /xCi 2-deoxy-D-[3H]glucose or 50 /zM L-[1- 
14C]glucose. The Krebs solution used for 2-deoxy-D- 
glucose uptake did not contain D-glucose and for 
some experiments it contained 100 /zM phlorizin. In 
some uptake experiments, NaC1 of Krebs solution 
was replaced isoosmotically by choline C1 or KC1 or 
NaSCN or mannitol. In inhibition experiments cells 
were preincubated at 37°C for 5 min with 2 mM 
different compounds. In kinetic experiments GSH 
uptake into cells was measured after 1 min of incuba- 
tion (GSH uptake was linear up to 3 min), using 
different concentrations of GSH (100-800 /xM). 
The saturation kinetic and the values of K m and 
Vma x were obtained by non-linear regression analysis 
after subtraction of the non-saturable component of 
GSH uptake. 
To estimate the radiolabeled GSH absorbed on 
membrane surface of cells, uptake at 4°C (on ice) was 
also studied. 
In all experimental conditions, after suitable incu- 
bation times, transport of radiolabeled compounds 
was stopped by the addition of 3 ml ice-cold Krebs 
solution (containing unlabeled GSH in experiments 
of GSH uptake). The mixture was then quickly fil- 
tered through a nitrocellulose filter and washed with 
3 + 3 ml Krebs solution. Cell-associated radioactivity 
found on the filters was determined in a liquid scintil- 
lation counter. All values were corrected for radioac- 
tivity associated with filters when uptake mixture was 
filtered without incubation. 
2.3. Unlabeled GSH uptake by HPLC analysis 
Confluent cells (~  2 X 10 6 cells) were washed 
with PBS and incubated at 37°C in Krebs solution pH 
7.4 (7 ml) containing 1 mM dithiothreitol, 5 mM 
unlabeled GSH or a mixture of 5 mM Gly, Cys, Glu. 
In some experiments cells were preincubated for 60 
min with 1 mM L-buthionine sulfoximine (BSO) and 
0.5 mM Acivicin (AT125), then washed with PBS and 
added with Krebs solution containing 5 mM unla- 
beled GSH. 
In GSH effiux experiments cells were incubated 
with Krebs solution without GSH. At suitable inter- 
vals GSH uptake or effiux were terminated by aspira- 
tion of the incubation mixture followed by rapid 
washing with 10 ml Krebs solution for two times. 
Cellular GSH was extracted with 1 ml HC104 5%; 
then cells were collected by scraping, added with 50 
/zl of 1 mM y-glutamylglutamate (internal standard) 
and sonicated for 5 s three times. The homogenate 
was centrifuged (12000 x g for 15 min); the precipi- 
tate was solubilised in 0.5 M NaOH and used for 
protein determination. 
The supernatant was neutralized with 2 mM 
K2CO3, centrifuged again and used to assay GSH 
content by HPLC as described by the method of 
Fariss et al. [24]. 
2.4. Trans-stimulation experiments 
Cells cultured in 22 mm dishes were preloaded 
with GSH by adding 10 mM unlabeled GSH in BME, 
after 12 h of incubation at 37°C, medium containing 
GSH was aspirated and cells were washed twice in 
PBS and then incubated at 37°C in 1 ml Krebs 
solution pH 7.4 containing 1 mM dithiothreitol, 200 
/zM GSH and 0.4 ~Ci [3H]GSH. At determined 
times (5-40 min), uptake was terminated by aspira- 
tion of the incubation mixture, followed by rapid 
washing with ice-cold 3 ml Krebs solution two times. 
Cells were then solubilized in 0.5 ml 1 M NaOH, 
neutralized with acetic acid and assayed for radioac- 
tivity in a liquid scintillation counter. All values were 
corrected for radioactivity found when uptake mix- 
ture was added without incubation. An aliquot of the 
NaOH extract was removed for protein determina- 
tion. GSH content in cells with and without (control) 
preloading of 10 mM unlabeled GSH was determined 
by HPLC analysis as previously described. 
2.5. Enzyme assay 
Cells (~  20 X 106) were washed twice with PBS, 
collected by scraping and centrifuged at 1000 X g for 
10 min; the pelleted cells were resuspended in 2 mM 
Tris buffer containing 50 mM mannitol at pH 7 and 
lysed by sonication at 4°C. The homogenate was 
centrifuged at 1000 X g for 10 min in a microcentri- 
fuge; the supernatant was again centrifuged at 10000 
X g for 25 min. The supernatant was used to assay 
the y-glutamylcysteine synthetase (y-GCS), GSH-S- 
transferases (GST), GSSG-reductase (GR) and GSH- 
peroxidase (GPx) activities. The precipitate was used 
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to assay T-GT. The precipitate was collected, washed 
and centrifuged again; then the pellet, containing 
partially purified plasma membranes, was dissolved 
in the same buffer and used for T-GT activity deter- 
mination with a commercially available assay kit 
(Boehringer, Mannheim) using y-glutamyl-p-nitro- 
anilide and glycylglycine as substrates. After 60 min 
at 37°C, the reaction mixture was centrifuged at 
12000Xg for 5 min and in the supematant the 
p-nitroaniline formation was determined at 405 nm. 
T-GT activity was also measured using whole cells 
by the method previously described, as also reported 
by others [25]. All other enzyme activities were 
assayed as described in a previous work [26]. 
2.6. Protein determination 
The protein concentration was determined by 
Bradford method [27]. Bovine serum albumin (Sigma) 
was used as standard. 
2.7. Statistical analyses 
Statistical analyses were evaluated using Student's 
t-test by computer program on the Philips 
PR07BM743. A difference of P < 0.05 was consid- 
ered significant. 
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Fig. 1. Time-course of GSH uptake into I407 cells. GSH uptake 
was carried out at 37°C in 8 X 105 cells in Krebs solution pH 7.4 
containing 200 /xM GSH and 0.4 /xCi [3H]GSH (O), 150 mM 
NaCI was replaced by 150 mM choline CI (O), or 150 mM KCI 
([]) or 300 mM mannitol (/x). L-Glucose uptake was carried out 
at 37°C in 8 × 105 cells in Krebs solution pH 7.4 containing 50 
/xM L-[ t4C]glucose (• ) .  The data are the means _+ S.E.M. of four 
experiments performed in triplicate. * P < 0.05; * * P < 0.005 
when compared to values measured in presence of 150 mM 
NaC1. 
3. Results 
3.1. GSH levels and GSH-related enzymes in 1407 
cells 
GSH intracellular levels and specific activities of 
GSH-related enzymes were measured to verify the 
effective occurrence of GSH metabolism (Table 1). 
Table 1 shows that in these cells are present both the 
regulator enzyme of intracellular GSH synthesis, T- 
GCS, and the enzymes involved in the detoxifying 
and reducing action of GSH, i.e., GST, GPx and GR. 
Membrane enzyme activity, T-GT, was also mea- 
sured, either using whole cells or partially purified 
membranes; no activity was detectable. As control of 
membrane integrity and purification we also mea- 
sured the specific activity of a typical membrane 
enzyme, alkaline phosphatase, which shows an en- 
richment factor of about 13-fold when compared to 
the specific activity in total cell homogenate. The 
Table 1 
GSH levels and GSH-related enzymes in I407 cells 
GSH T-GCS GST GR GPx 
21.5 ± 1.0 0.16 ± 0.014 0.016 ± 0.002 0.016 ± 0.002 0.02 ± 0.003 
GSH levels are measured by HPLC analysis and expressed as nmol/mg protein. Specific activities of enzymes are expressed as 
/zmol/mg protein per min. Data are means _+ S.E.M. of three experiments performed in duplicate. T-GCS, y-glutamylcysteine synthetase; 
GST, GSH-S-transferases; GR, GSSG-reductase; GPx, GSH-peroxidase. 
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lack of y-GT allowed us to study GSH uptake with- 
out the interference of this enzyme activity. 
3.2. Transmembrane-mediated transport of GSH in 
1407 cells 
Fig. 1 shows that GSH was taken up into the cells 
in a time-dependent manner and the time-course of 
GSH uptake was different from that of L-glucose, 
which showed a typical diffusional behaviour. The 
GSH uptake time-course did not change when a 
similar Na + or choline + gradient was present in 
extracellular uptake media (Krebs solution modified) 
indicating the absence of a Na+-dependent trans- 
porter. The replacement of extracellular Na + with an 
equal K + concentration i creased GSH uptake values 
by about 50% for short incubation times; on the 
contrary, when Na + concentration was substituted 
with mannitol, very low values of GSH uptake were 
detected. The GSH uptake values measured in the 
presence of K + or mannitol were statistically differ- 
ent from those obtained in the presence of Na + in 
Krebs solution. The equilibrium values of GSH up- 
take were reached after 40 min of incubation and 
were approximately the same, indicating that differ- 
ent experimental conditions did not alter cellular 
volume. 
The subsequent experiments to characterize GSH- 
mediated transport were performed in Krebs solution, 
in the presence of extracellular Na + gradient as it 
occurs in physiological conditions. To verify the 
aspecific binding of GSH on membrane surface of 
cells, GSH uptake experiments were performed at 
4°C; the values of labeled GSH measured after differ- 
ent incubation times were similar and very low when 
compared to those obtained at 37°C, indicating ne- 
glegible GSH binding (data not shown). 
Moreover, GSH transport into I407 cells was con- 
firmed by GSH uptake time-course obtained by HPLC 
measurements of intracellular GSH levels after differ- 
ent times of incubation with unlabeled GSH in Krebs 
solution (Fig. 2). Other experiments were performed 
to confirm the uptake of intact GSH by a transport 
system and to exclude intracellular increases of GSH 
levels due to its extracellular degradation and the 
subsequent uptake of its three constituent amino acids 
followed by GSH intracellular resynthesis. Effec- 
tively, no difference in GSH uptake time-course val- 
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Fig. 2. Time-course of GSH uptake measured by HPLC analysis 
into I407 cells. GSH uptake was carried out at 37°C in 2× 106 
cells in Krebs solution pH 7.4 containing 5 mM unlabeled GSH. 
The values are the means _+ S.E.M. of three experiments after 
substraction of GSH intracellular content measured in cells incu- 
bated in Krebs solution without GSH. 
ues was measured by HPLC analysis whether cells 
were preincubated for 60 min in Krebs solution with 
or without an addition of 1 mM BSO (a specific 
inhibitor of y-GCS) and 0.5 mM AT125 (a specific 
inhibitor of y-GT). Moreover, no increase in intra- 
cellular GSH levels was measured at different time 
intervals when uptake solution contained only a mix- 
ture of 5 mM Gly, Cys, Glu (data not shown). These 
experiments indicated no involvement of y-GT 
and/or endogenous metabolism of GSH in the time- 
course of GSH uptake. Finally, GSH effiux from 
cells was also tested by HPLC analysis, incubating 
cells up to 90 min in Krebs solution; no change in the 
intracellular content of GSH was found (data not 
shown). 
Since no metabolite transport system in 1407 mem- 
branes was identified, the time-courses of Na+-de - 
pendent and Na+-independent transport of 2-deoxy- 
D-glucose (2-D-Glu) were measured (Fig. 3). The 
presence of an active transport of 2-D-Glu by specific 
inhibition of phlorizin was confirmed. In fact, 2-D- 
Glu uptake decreased significantly in the presence of 
phlorizin or when Na + was substituted with K +. The 
time-courses of GSH and 2-D-Glu uptake in Krebs 
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Fig. 3. Time-course of 2-deoxy-D-glucose uptake into I407 cells. 
2-D-Glu uptake was carried out at 37°C in 8× 105 cells in Krebs 
solution pH 7.4 containing 200 p~M 2-D-GIu and 0.8 /xCi 
2-D-[3H]GIu without (111) and with 100 /zM phlorizin (Q). 150 
mM of NaCI was replaced by 150 mM KCI (O). The values are 
the means_+ S.E.M. of four experiments performed in triplicate. 
*P < 0.05; * * P < 0.005 when compared to values measured in
presence of 150 mM NaC1. 
solution were similar: both reached the highest up- 
take values during the first minutes of incubation, 
confirming the presence of a mediated transport sys- 
tem for GSH. 
Na + was replaced with K +, which is able to depolar- 
ize the plasma membrane of these cells at high 
extracellular concentrations [22]. On the contrary, 
GSH uptake values decreased (about 35%) when 
anion C1 was substituted with the more permeant 
anion SCN- ,  which may hyperpolarize the electrical 
membrane potential [28,29]. The equilibrium values 
measured after 40 min of incubation did not vary in 
different experimental conditions. 
3.4. Concentration dependence of GSH uptake 
To test whether the GSH uptake in I407 cells 
reflects a transport-mediated process, the initial rate 
of uptake was determined at different GSH concen- 
trations. Since linearity with incubation time was 
observed up to 3 min, GSH uptake was measured 
after 1 min of incubation in the range of substrate 
concentrations (100-800 tzM). The results show a 
diffusional component at the highest GSH concentra- 
tions (Fig. 4). Saturation kinetic for different sub- 
strate concentrations was obtained by subtracting the 
diffusional component. This indicates the presence of 
a single GSH mediated transport system. 
150 
3.3. Effect of membrane potential on GSH uptake in 
1407 cells 
Table 2 shows that GSH uptake value at 5 min of 
incubation was affected by changes in membrane 
potential. In fact, a significant increase in GSH up- 
take (about 60%) was measured when extracellular 
Table 2 
Effect of membrane potential on GSH uptake into I407 cells. 
Incubation time (min) Uptake (pmol GSH/mg protein) 
NaC1 (control) KCI NaSCN 
5 75_+ 8 120_+ 5 ~ 50-+ 3.5 a 
40 140_+23 160_+ 10 170_+20 
GSH uptake was carried out at 37°C in 8 × 105 cells in Krebs 
solution pH 7.4 containing 200 /xM GSH and 0.4/xCi [3H]GSH 
(control) or in Krebs solution modified by substitution of 150 
mM NaC1 with 150 mM KCI or with 150 mM NaSCN. The data 
represent means -+_ S.E.M. of three experiments performed in trip- 
licate. 
~P < 0.05 when compared to controls. 
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Fig. 4. Effect of varying GSH concentrations on the initial rate of 
GSH uptake into I407 cells. GSH uptake was carried out at 37°C 
in 8 × 105 cells in Krebs solution pH 7.4 containing different 
concentrations of GSH and [3H]GSH (100-800 /xM) (O). The 
dashed line is a graphical estimate of the non-saturable compo- 
nent of GSH uptake. The continuous line shows the saturation 
kinetic obtained by non-linear regression, i.e. by fitting the 
equation V = (Vmax[S] / K m + [S]) + Ko[S] to the experimental 
data. The data are the means -+ S.E.M. of three experiments 
performed in triplicate, g m = 90 txM + 20; Vma x= 50 + 5 
pmol/min per mg protein. K~ = 0.09 pmol/min per mg protein. 
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3.5. Trans-stimulation of GSH uptake in 1407 cells 
A typical trans-stimulation experiment with cells 
preloaded with unlabeled GSH was performed to 
confirm the presence of a carrier mediated transport 
of GSH [18]. Table 3 shows that an increase of 
intracellular GSH (about 200%) stimulated extracel- 
lular GSH uptake, with an increase of approximately 
50% after 5 min of incubation as compared to con- 
trol. This activation effect due to the acceleration of 
external substrate transport into cells by internal sub- 
strate is interpreted as a counter-exchange of the 
external with the internal substrate by transporter. 
This activation effect on GSH uptake was not due to 
volume variation, considering that the equilibrium 
values measured after 40 min of incubation were 
similar. 
3.6. Effect of GSH-structurally related compounds on 
GSH uptake in 1407 cells 
To verify the specificity of this transport system, 
the effect of different structurally related compounds 
on GSH uptake was studied. A significant inhibitory 
effect on the rate of GSH uptake after 5 min of 
incubation was measured only in the presence of 
GSH S-conjugates and GSH-ethyl ester, while GSSG 
was responsible for a significant activation effect 
(Table 4). 
To exclude a possible GSH active transport, the 
effect of 1 mM ouabain on GSH uptake was studied; 
no alteration in GSH uptake values was measured, 
Table 4 
Effect of structurally related compounds on GSH uptake into 
1407 cells 
Addition GSH uptake 
(pmol/mg protein) 
None (Control) 80+ 4.0 
Glycine 75 _+ 10.0 
Glutamic acid 73+ 8.0 
Cysteine 70 + 10.0 
y-Glu-Gly 70,+ 9.0 
Gly-Gly-Gly 70,+ 9.0 
Gly-sarcosine 77 _+ 10.0 
PNB-SG 50,+ 5.0 ( - 38) ~ 
E-SG 45+ 4.4(--45) b 
GSSG 107 + 6.4 ( + 34) " 
GSH-ethyl ester 45 ,+ 3.3 ( -  45) ~' 
Probenecid 80_+ 6.0 
Ophthalmic acid 70_+ 6.0 
(y-Glu-a-aminoisobutyrate-Gly) 
GSH uptake was carried out at 37°C in 8× 105 cells in Krebs 
solution pH 7.4 containing 200 /xM GSH and 0.8 /xCi [3H]GSH 
and in the absence or presence of 2 mM different compounds 
after 5 min of incubation. Data are the means + S.E.M. of three 
experiments performed in triplicate. The values in parentheses are 
the percentage changes of GSH uptake compared with control 
value. PNB-SG, S-p-nitrobenzyl-GSH; E-SG, S-ethyl GSH. 
"P < 0.05, bp < 0.005 when compared to controls. 
nor was any direct influence of 1 mM ATP on 
transporter activity observed (data not shown). 
4. Discussion 
Table 3 
Trans-stimulation of GSH uptake into 1407 cells 
GSH Uptake (pmol GSH/  
(nmol/mg protein) mg protein) 
5 min 40 min 
Control 23.3_+ 1.5 240_+ 35 680_+ 100 
Preloaded cells 70 _+12 a 380_+40 ~ 700_+ 40 
Cells with and without (control) preloading of 10 mM unlabeled 
GSH were employed. GSH uptake was carried out in Krebs 
solution pH 7.4 containing 200 /xM GSH and 0.4/xCi [3H]GSH. 
Unlabeled GSH content in cells preloaded with and without GSH 
was measured by HPLC analysis. Values are means + S.E.M. of 
four experiments performed in triplicate. 
ap < 0.05 when compared to controls. 
The present study shows for the first time a GSH 
specific transport system in human intestinal cells 
and it defines some characteristics of its transport 
activity. Moreover GSH metabolism in I407 cells has 
been confirmed measuring the specific activity of 
GSH-related enzymes. T-GCS and GPx activity val- 
ues are similar to those measured in human ileum and 
colon, while GST and GR values are lower [1,11]. 
Various data confirm the existence of mediated trans- 
port of GSH into I407 cells: (1) The fast uptake at 
short incubation time similar to that observed in 
glucose uptake by Na+-dependent and independent 
transport. (2) The behaviour of the time-course of 
GSH uptake obtained by HPLC measurements, per- 
formed also in experimental conditions that exclude 
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the involvement of "y-GT and y-GCS activity. (3) The 
saturation kinetic obtained after subtraction of the 
diffusional component, which is often observed in 
amino acid and peptide transport measurements [30]. 
(4) The trans-stimulation effect on GSH uptake in 
GSH-preloaded cells, similar to that previously mea- 
sured in rabbit brush-border membrane vesicles 
(BBMV) [ 18]. In rat hepatocytes an analogous obser- 
vation was also utilized to confirm the presence of 
GSH mediated transport [31]. (5) Inhibition of GSH 
uptake by GSH-related compounds, as also previ- 
ously demonstrated in rabbit BBMV [18]. 
These results indicate that GSH uptake in I407 
cells may occur only by a facilitated Na+-indepen - 
dent transport system, considering the lack of y-GT 
activity and the similar behaviour observed in the 
time course of GSH uptake when extracellular Na + is 
substituted with choline+; this conclusion is also 
supported by the different behaviour of GSH uptake 
with respect to that of glucose in the presence of 
extracellular K +. 
As regards T-GT activity, our data may be in 
agreement with Meister et al. [32] who measured very 
low y-GT activity in crypt cells of the rat jejunal 
mucosa. There are also other findings which show 
that the maximum expression of T-GT activity is 
related to the differentiation of enterocytes [33]. In- 
deed, some characteristics of both glucose trans- 
porters also seem related to enterocyte differentiation 
[34]. The fact that I407 cells are undifferentiated 
could also explain the lack of a Na+-dependent GSH 
transport system in these cells; while this system has 
been identified in rat intestinal basolateral mem- 
branes [19]. The presence of a single GSH transport 
system in I407 cells is further confirmed by the 
kinetic analysis. Moreover, GSH transport in I407 
cells is increased when cations are present in the 
medium, but an activation effect by a specific cation 
gradient is excluded, considering that all cations used 
in extracellular medium increase GSH uptake with 
respect o uptake values obtained when cations are 
replaced with mannitol. The increase of the GSH 
transport rate by extracellular cations may be ex- 
plained considering that at physiological pH values 
GSH is negatively charged, and extracellular cations 
may neutralize this negative charge by cotransport 
with GSH. It is also possible that cations interact 
directly with the transporter and increase its transport 
activity by inducing an optimal conformational state, 
as we suggested in a previous work [29]. These 
results are in part different from findings obtained in 
rabbit BBMV [16,29], in which GSH uptake values 
are similar in the presence of Na + or K + in extraves- 
icular medium and higher than those measured in the 
presence of choline + . Probably these different find- 
ings are related to membrane potential changes that 
occur in I407 cells and not in rabbit BBMV, when 
Na + in uptake medium is replaced with K + or 
choline +. However, GSH transport systems character- 
ized in rabbit BBMV, in rat liver and kidney cell 
membranes are also remarkably affected by mem- 
brane potential [29]. In I407 cells membrane depolar- 
ization, with a decrease in intracellular negative 
charge, increases GSH uptake values, while a mem- 
brane hyperpolarization btained using thiocyanate is 
responsible for a GSH uptake decrease. It is interest- 
ing to compare our data with those showed in iso- 
lated rat hepatocytes, where, under similar experi- 
mental conditions, opposite results are obtained re- 
garding GSH effiux: in fact, the increase in concen- 
tration of medium K + or choline + instead of Na + 
causes a parallel fall both in membrane potential and 
GSH effiux, while hyperpolarization f hepatocytes 
with lipophilic anion thiocyanate is associated with 
significant increased efflux [28,31]. Since I407 cells 
retain receptors for intestinal secretogogues [22,35] 
that may change transmembrane potential by alter- 
ation of K + membrane conductance and cytosolic 
Ca 2+ content, it is possible to hypothesize an hor- 
monal control mechanism of GSH transport in these 
cells. Indeed, both a stimulation of GSH absorption 
in rat small intestine by a-adrenergic agonists medi- 
ated by Ca2+-calmodulin dependent mechanisms [21] 
and an hormonal control of GSH effiux from hepato- 
cytes mediated by changes in membrane potential 
[36] have been demonstrated. 
The present results also indicate a remarkable 
affinity and specificity of this transporter for GSH; in 
fact, K m value is very low if compared either to 
other values measured in membrane vesicles or to 
intact cells for GSH transport systems and other 
peptides [16,37]. Moreover the high specificity of this 
transporter for the entire structure of GSH is con- 
firmed by the GSH uptake inhibition obtained only 
by compounds strictly related to GSH, such as GSH- 
S-conjugates and GSH-ethyl ester. These data are 
282 T. lantomasi et al. / Biochimica et Biophysica Acta 1330 (1997) 274-283 
partly in agreement with those previous obtained on 
the GSH transport system in rat intestinal and renal 
BBMV [29,38] and on the GSH low-affinity transport 
system present in rat liver canalicular membrane 
vesicles [37]. On the contrary, this inhibition picture 
differs greatly from that shown in intestinal or renal 
basolateral membrane vesicles [39,40] and in rat liver 
sinusoidal membrane [31]. These data also suggest 
the possibility that GSH-S-conjugates cross human 
intestinal membrane by the same GSH transport sys- 
tem as previously demonstrated in rabbit intestinal 
membranes [29] (other studies should be performed 
to confirm this). Recently, a GSH-S-conjugate medi- 
ated transport in Caco-2 cells (human colon adeno- 
carcinoma cell line) has been identified [20]. An 
apparently contrasting effect regards the increase of 
GSH uptake value induced by GSSG (a GSH homo- 
conjugate), which has been shown to be unable to 
affect GSH transport activity in rabbit intestine [29]; 
this result may be explained by hypothesizing the 
requirement of disulfide groups and/or the occur- 
rence of thiol-disulfide exchange reactions in the 
transporter in order to increase its transport activity. 
Recent findings show that the bidirectional sinusoidal 
GSH transport in hepatocytes i modulated by the 
thiol-disulfide status, with a GSH efflux stimulation 
by dithiothreitol (thiol reduction) and a GSH uptake 
stimulation by cystine (thiol oxidation) [41]. 
It would be interesting to investigate further this 
GSSG effect in human GSH intestinal transport, con- 
sidering that GSSG is present in a variety of foods 
[42] and that it may enter the body by the diet. 
Moreover, both GSH and GSSG are important in the 
maintenance of the luminal thiol-disulfide ratio, which 
is involved in regulating the transport and protection 
activity of epithelial cells as well as the turnover of 
mucus and enterocytes [16,43]. In conclusion, the 
characterization f GSH metabolism and transport in 
1407 cells may contribute to clarify the role of GSH 
in human intestine, which through the GSH interor- 
gan cycle may be correlated to the liver and kidney in 
its detoxifying and antioxidant action. Moreover, the 
presence of GSH transporter in human epithelial in- 
testinal cells may confirm the possible efficacy of 
GSH oral therapy to increase GSH levels in intestine 
and in other organs, in particular for the treatment of 
disease processes involving oxidative or electrophilic 
damage. 
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